You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|
|---|---|
| Published in |
Diabetes Care, September 2015
|
| DOI | 10.2337/dc15-1419 |
| Pubmed ID | |
| Authors |
Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian J. Rewers, Desmond A. Schatz, Jay S. Skyler, Jay M. Sosenko, Anette-G. Ziegler |
| Abstract |
Insights from prospective, longitudinal studies of individuals at risk for developing type 1 diabetes have demonstrated that the disease is a continuum that progresses sequentially at variable but predictable rates through distinct identifiable stages prior to the onset of symptoms. Stage 1 is defined as the presence of β-cell autoimmunity as evidenced by the presence of two or more islet autoantibodies with normoglycemia and is presymptomatic, stage 2 as the presence of β-cell autoimmunity with dysglycemia and is presymptomatic, and stage 3 as onset of symptomatic disease. Adoption of this staging classification provides a standardized taxonomy for type 1 diabetes and will aid the development of therapies and the design of clinical trials to prevent symptomatic disease, promote precision medicine, and provide a framework for an optimized benefit/risk ratio that will impact regulatory approval, reimbursement, and adoption of interventions in the early stages of type 1 diabetes to prevent symptomatic disease. |
X Demographics
The data shown below were collected from the profiles of 51 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 20 | 39% |
| United Kingdom | 5 | 10% |
| Australia | 3 | 6% |
| Spain | 3 | 6% |
| Canada | 2 | 4% |
| Tanzania, United Republic of | 1 | 2% |
| Italy | 1 | 2% |
| Switzerland | 1 | 2% |
| Armenia | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 14 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 63% |
| Practitioners (doctors, other healthcare professionals) | 9 | 18% |
| Science communicators (journalists, bloggers, editors) | 5 | 10% |
| Scientists | 5 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 800 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Sweden | 1 | <1% |
| Unknown | 798 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 91 | 11% |
| Student > Bachelor | 89 | 11% |
| Student > Master | 85 | 11% |
| Researcher | 78 | 10% |
| Student > Doctoral Student | 48 | 6% |
| Other | 128 | 16% |
| Unknown | 281 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 203 | 25% |
| Biochemistry, Genetics and Molecular Biology | 81 | 10% |
| Immunology and Microbiology | 40 | 5% |
| Agricultural and Biological Sciences | 32 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 31 | 4% |
| Other | 113 | 14% |
| Unknown | 300 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 417. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2024.
All research outputs
#70,947
of 25,837,817 outputs
Outputs from Diabetes Care
#117
of 10,760 outputs
Outputs of similar age
#777
of 283,043 outputs
Outputs of similar age from Diabetes Care
#1
of 96 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,760 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,043 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.